These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 20601039)
21. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885 [TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis: what is it and when should it be used? Scarisbrick J Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836 [TBL] [Abstract][Full Text] [Related]
23. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure. Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140 [TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Greinix HT; Volc-Platzer B; Kalhs P; Fischer G; Rosenmayr A; Keil F; Hönigsmann H; Knobler RM Blood; 2000 Oct; 96(7):2426-31. PubMed ID: 11001894 [TBL] [Abstract][Full Text] [Related]
26. [Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases]. D'incan M; Kanold J; Halle P; De Lumley L; Souteyrand P; Deméocq F Ann Dermatol Venereol; 2000 Feb; 127(2):166-70. PubMed ID: 10739974 [TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease. Sbano P; Rubegni P; De Aloe GB; Guidi S; Fimiani M Bone Marrow Transplant; 2004 Apr; 33(8):869-70. PubMed ID: 14743190 [No Abstract] [Full Text] [Related]
28. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work? Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600 [TBL] [Abstract][Full Text] [Related]
29. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence. Woltz P; Castro K; Park BJ Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945 [TBL] [Abstract][Full Text] [Related]
30. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Greinix HT; Knobler RM; Worel N; Schneider B; Schneeberger A; Hoecker P; Mitterbauer M; Rabitsch W; Schulenburg A; Kalhs P Haematologica; 2006 Mar; 91(3):405-8. PubMed ID: 16531267 [TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Weitz M; Strahm B; Meerpohl JJ; Bassler D Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961 [TBL] [Abstract][Full Text] [Related]
32. Steroid-sparing effect of extracorporeal photopheresis in the treatment of graft-vs-host disease. Coyle TS; Nam TK; Camouse MM; Stevens SR; Baron ED Arch Dermatol; 2004 Jun; 140(6):763-4. PubMed ID: 15210480 [No Abstract] [Full Text] [Related]
33. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S; Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274 [TBL] [Abstract][Full Text] [Related]
34. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018 [TBL] [Abstract][Full Text] [Related]
36. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ; Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088 [TBL] [Abstract][Full Text] [Related]
37. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital. Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106 [TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Weitz M; Strahm B; Meerpohl JJ; Bassler D Cochrane Database Syst Rev; 2014 Feb; (2):CD009759. PubMed ID: 24569960 [TBL] [Abstract][Full Text] [Related]
39. Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: a case report. Sirinoglu Demiriz I; Tekgunduz E; Tetik A; Kayikci O; Altuntas F Transfus Apher Sci; 2013 Feb; 48(1):109-11. PubMed ID: 23017807 [TBL] [Abstract][Full Text] [Related]
40. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children. Goussetis E; Varela I; Tsirigotis P Transfus Apher Sci; 2012 Apr; 46(2):203-9. PubMed ID: 22079263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]